Renovaro Inc. (RENB:NASDAQ) closed at $1.42 on March 9, 2026, unchanged on the day. The stock trades 93.2% below its 52-week high of $21.00 and 27.9% above its 52-week low of $1.11. Renovaro Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, RENB closed higher on 26 days (10%). Its best day was March 23, 2026 (+202.77%) and its worst was January 27, 2026 (-40.92%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 5 times.
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies. The company develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccines and cures and Cellular immune-oncology products.
Find more stocks like RENB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.